AgeX Therapeutics Inc., Alameda, CA, 94501, USA.
Gerontology Research Group, Los Angeles, 90024, USA.
Biochem Biophys Res Commun. 2020 May 7;525(3):563-569. doi: 10.1016/j.bbrc.2020.02.092. Epub 2020 Feb 27.
Supercentenarians (≥110-year-old, SC) are a uniquely informative population not only because they surpass centenarians in age, but because they appear to age more slowly with fewer incidences of chronic age-related disease than centenarians. We reprogramed donor B-lymphoblastoid cell lines (LCL) derived from a 114-year-old (SC), a 43-year-old healthy disease-free control (HDC) and an 8-year-old with a rapid aging disease (Hutchinson-Gilford progeria syndrome (HGPS)) and compared SC-iPSC to HDC-iPSC and HGPS-iPSCs. Reprogramming to pluripotency was confirmed by pluripotency marker expression and differentiation to 3 germ-layers. Each iPSC clone differentiated efficiently to mesenchymal progenitor cells (MPC) as determined by surface marker expression and RNAseq analysis. We identified supercentenarian and HGPS associated gene expression patterns in the differentiated MPC lines that were not evident in the parental iPSC lines. Importantly, telomere length resetting occurred in iPSC from all donors albeit at a lower incidence in supercentenarian iPSCs. These data indicate the potential to use reprogramming to reset both developmental state and cellular age in the "oldest of the old." We anticipate that supercentenarian iPSC and their differentiated derivatives will be valuable tools for studying the underlying mechanisms of extreme longevity and disease resistance.
超级人瑞(≥110 岁,SC)是一个非常有信息价值的群体,不仅因为他们的年龄超过了百岁老人,还因为他们的衰老速度似乎更慢,患有慢性与年龄相关疾病的情况也比百岁老人少。我们对来自一位 114 岁(SC)、一位 43 岁健康无疾病对照者(HDC)和一位 8 岁患有快速衰老疾病(Hutchinson-Gilford 早老综合征(HGPS))的供体 B 淋巴细胞系(LCL)进行了重新编程,并将 SC-iPSC 与 HDC-iPSC 和 HGPS-iPSC 进行了比较。通过多能性标志物的表达和向 3 个胚层的分化,证实了重新编程为多能性。每个 iPSC 克隆通过表面标志物表达和 RNAseq 分析有效地分化为间充质祖细胞(MPC)。我们在分化的 MPC 系中发现了与超级人瑞和 HGPS 相关的基因表达模式,而在亲本 iPSC 系中则没有明显表现。重要的是,尽管在超级人瑞的 iPSC 中发生率较低,但所有供体的 iPSC 中都发生了端粒长度重置。这些数据表明,有可能利用重新编程来重置“最老的老年人”的发育状态和细胞年龄。我们预计,超级人瑞 iPSC 及其分化衍生物将成为研究极端长寿和抗疾病机制的有价值工具。